About Lumigen
Lumigen is a Healthcare company based in Southfield (United States) founded in 1987, and was acquired by Beckman Coulter in October 2006. Chemiluminescent reagents are manufactured for biotechnology applications. It operates on a Reseller / Distribution model. Lumigen offers products and services including Lumigen SPARCL, Lumigen HyPerBlu, and Lumigen ECL Ultra (TMA-6). Its focus areas include Diagnostics and Clinical Immunodiagnostics. Its legal entity is Lumigen®.
Company details
Lumigen is established as one of the largest suppliers of chemiluminescent reagents to the clinical immunodiagnostics market. The company is engaged in researching, developing, manufacturing, and marketing novel chemiluminescent compounds. These compounds are utilized in life science research and medical diagnostics worldwide. Solutions provided by Lumigen are integrated into automated systems for detecting alkaline phosphatase conjugates and conducting ultra-sensitive chemiluminescent ELISA assays. Additionally, Western blotting detection of horseradish peroxidase conjugates is supported in life science research. Innovation in detection technologies for clinical laboratories and research communities is continuously pursued by Lumigen.
- Headquarters Southfield, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website lumigen.com
- Acquired by Beckman Coulter (Oct 2006)
- Legal Name Lumigen®
- Investors
- Acquired byBeckman Coulter
(Oct 2006)
Products & Services of Lumigen
Lumigen offers a comprehensive portfolio of products and services, including Lumigen SPARCL, Lumigen HyPerBlu, and Lumigen ECL Ultra (TMA-6).
Used for sensitive detection in diagnostic assays.
Applied in diagnostics for enhanced detection sensitivity.
Utilized for ultra-sensitive chemiluminescent ELISA assays.
Investors in Lumigen
Lumigen has secured backing from 1 investor. Prominent investors backing the company include Beckman Coulter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical diagnostic products are manufactured for biomedical testing. | 1935 | beckmancoulter.com | Brea, United States |
Investor details for Lumigen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Lumigen
2 dated milestones of Lumigen across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Lumigen is founded.
- Exit Acquired by Beckman Coulter.
Web traffic of Lumigen
Websites that share an audience with Lumigen (lumigen.com).
Websites whose visitors overlap most with Lumigen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mpiresearch.com | 100% | View details | |||
| vai.org | 100% | 36.3K | #787,837 | View details | |
| immunochemistry.com | 91% | View details | |||
| msu.edu | 66% | 6.4M | #7,912 | View details | |
| oakland.edu | 66% | 1.1M | #50,893 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Lumigen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Diagnostics & Medical Devices
3 companies that operate in the same segment as Lumigen (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 20.63 B | 53,000 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | ||||
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lumigen
Lumigen was founded in 1987.
Lumigen is headquartered in Southfield, United States. It is registered at Southfield, Michigan, United States.
Lumigen is established as one of the largest suppliers of chemiluminescent reagents to the clinical immunodiagnostics market. The company is engaged in researching, developing, manufacturing, and marketing novel chemiluminescent compounds. These compounds are utilized in life science research and medical diagnostics worldwide. Solutions provided by Lumigen are integrated into automated systems for detecting alkaline phosphatase conjugates and conducting ultra-sensitive chemiluminescent ELISA assays. Additionally, Western blotting detection of horseradish peroxidase conjugates is supported in life science research. Innovation in detection technologies for clinical laboratories and research communities is continuously pursued by Lumigen.
Lumigen offers Lumigen SPARCL, Lumigen HyPerBlu, and Lumigen ECL Ultra (TMA-6).
Lumigen has 1 investor. Key investors include Beckman Coulter.
Lumigen operates through Lumigen®.
Yes. Lumigen was acquired by Beckman Coulter in October 2006.